Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to learn if Belatacept is effective and safe as a first line of
immunosuppression treatment in patients undergoing a renal transplant where the donor kidney
is obtained in patients with extended criteria.